Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00828451 · ClinicalTrials.gov registry record · NA

Collaborative Research Group for Necrotizing Enterocolitis

A NA study of Prematurity and Necrotizing Enterocolitis, sponsored by Washington University School of Medicine.

Completed
Registry status
NA
Development phase
29
Enrollment target
1
Study location

NCT00828451 is a NA study of Prematurity and Necrotizing Enterocolitis that has completed, run by Washington University School of Medicine. The registered enrollment target is 29 participants, below the 210-participant average among 21 other Prematurity trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00828451, a NA study of Prematurity and Necrotizing Enterocolitis, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
NA
Development phase
29 participants
Enrollment target
1
Study location

Study Summary

This proposal will test the hypothesis that synthesis and catabolism of epidermal growth factor (EGF), the genotype of the EGF gene, and the microbiome interact to influence EGF expression in infants at risk for necrotizing enterocolitis (NEC).

Interventions

  • BIOLOGICAL [5,5,5-2H3]leucine (stable isotope labeled leucine)

Study Locations (1)

Missouri

  • St. Louis Children's Hospital - St Louis

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2008-05
Est. Completion 2010-12
Phase NA

What the Registry Record Tells You About NCT00828451

The ClinicalTrials.gov registry entry for NCT00828451 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 210-participant average among 21 other Prematurity trials with a reported enrollment target (86% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Prematurity appearing as the primary indexed condition, and to 1 intervention - of which [5,5,5-2H3]leucine (stable isotope labeled leucine) is the first listed.

NCT00828451 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT00828451 about?

NCT00828451 is a clinical study titled "Collaborative Research Group for Necrotizing Enterocolitis". This proposal will test the hypothesis that synthesis and catabolism of epidermal growth factor (EGF), the genotype of the EGF gene, and the microbiome interact to influence EGF expression in infants at risk for necrotizing enterocolitis (NEC).

What is the current status of trial NCT00828451?

This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2008-05. Estimated completion is 2010-12.

What conditions does trial NCT00828451 study?

This clinical trial studies the following conditions: Prematurity, Necrotizing Enterocolitis.

What interventions are being tested in trial NCT00828451?

The interventions under investigation include: [5,5,5-2H3]leucine (stable isotope labeled leucine) (BIOLOGICAL).

Who is sponsoring clinical trial NCT00828451?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00828451 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prematurity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.